Application of jolkinolide B in preparation of drugs for preventing and treating chronic kidney diseases
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for petrosalactone and chronic kidney disease, applied in the field of medicine, to reduce renal fibrosis, easy to use, and protect the kidneys
Active Publication Date: 2022-01-18
BEIJING UNIV OF CHINESE MEDICINE
View PDF6 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0007]
But so far there is no report
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0038] The present embodiment discloses a kind of tablet that takes petogenolide B as raw material medicine, and its composition is as follows:
[0039]
[0040] Take petroglide B, mix with hydroxypropyl methylcellulose, talcum powder, lactose, and magnesium stearate, add absolute ethanol to make soft material, pass through a 24-mesh sieve, make granules, dry, add Magnesium stearate, blended, compressed into tablets.
Embodiment 2
[0042] The present embodiment discloses a kind of capsule that takes petroglyptone B as raw material medicine, and its composition is as follows:
[0043]
[0044] Take petroglide B, mix evenly with starch, dextrin, and hydroxypropyl cellulose, add absolute ethanol to make a soft material, pass through a 24-mesh sieve, make granules, dry, add magnesium stearate, and mix well. Fill into capsules.
Embodiment 3
[0046] This embodiment discloses a kind of granule that takes petroglyptone B as raw material medicine, and its composition is as follows:
[0047]
[0048] Take petroglide B, mix with sucrose, starch, talcum powder, and croscarmellose sodium evenly, add absolute ethanol to make a soft material, pass through a 24-mesh sieve, make granules, dry, and add stearic acid Magnesium, mixed well, bagged.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides application of jolkinolide B in preparation of drugs for preventing and treating chronic kidney diseases. The jolkinolide B can inhibit epithelial-mesenchymal transdifferentiation by inhibiting activation of a TGF-beta/Smads pathway, thereby playing a role in kidney protection. The jolkinolide B can be used as various chronic kidney disease drugs with obstructive nephropathy and renal fibrosis as main pathological characteristics for clinical use.
Description
technical field [0001] The invention relates to the technical field of medicines, in particular to the application of petroglide B in the preparation of drugs for the prevention and treatment of chronic kidney disease. Background technique [0002] Currently, more than 10% of people in the world suffer from chronic kidney disease (CKD), and the number of patients is increasing year by year. With the rapid increase in the prevalence of CKD in recent years, it is particularly urgent to find safer and more effective CKD drugs. [0003] Jolkinolide B (Jolkinolide B) is an abietane-type diterpenoid isolated from the root of Euphorbia fischeriana (Euphorbiafischeriana), and its structural formula is as follows: [0004] [0005] Studies have reported that Jolkinolide B induces the expression of Caspase-3 protein in MDA-MB-231 breast cancer cells through mitochondrial release of cytochrome C, which has therapeutic applications in cancer (Oncol.Rep.2012,27:1976-1980.). Jolkinol...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more